Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (90)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hong, J.-Y.
Right arrow Articles by Yang, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hong, J.-Y.
Right arrow Articles by Yang, C. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1992 Oxford University Press

other

Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung

Jun-Yan Hong, Zhi Yuan Wang, Theresa J. Smith, Shiqi Zhou, Stephanie Shi, Jinmei Pan and Chung S. Yang 1

Laboratory for Cancer Research, College of Pharmacy, Rutgers University Piscataway, NJ 08555-0789, USA

1To whom correspondence should be addressed

Diallyl sulfide (DAS), a component of garlic oil, has been shown to inhibit tumorigenesis by several chemical carcinogens. Our previous work demonstrated that DAS inhibited the metabolic activation of carcinogenic nitrosamines, including the tobacco-specific 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in rat lung and nasal mucosa microsomes. In the present study, the effects of DAS on the tumorigenicity and the metabolism of NNK in A/J mouse lung were examined. Female A/J mice at 7 weeks of age were pretreated with DAS (200 mg7sol;kg body wt in corn oil, p.o) daily for 3 days. Two hours after the final DAS treatment, the mice were either given a single dose of NNK (2 mg/mouse, i.p.) and kept for an additional 16 weeks for determining the production of pulmonary tumors, or were killed immediately so as to measure the microsomal activity in metabolizing NNK. In comparison to the vehicle control group, DAS pretreatment significantly decreased the incidence of NNK-induced lung tumors (37.9 versus 100%) and the tumor multiplicity (0.6 versus 7.2 tumors/mouse). In pulmonary metabolism of NNK, DAS pretreatment reduced the rates of formation of keto aldehyde, keto alcohol, NNAL-N-oxide, and NNK-N-oxide by 70–90%. In addition, the formation of NNK oxidative metabolites from NNK in the liver microsomes from DAS-pretreated mice was remarkably reduced. DAS also inhibited the metabolism of NNK in mouse lung microsomes in vitro. These results demonstrate that DAS is an effective chemopreventive agent against NNK-induced lung tumorigenesis, probably by inhibiting the metabolic activation of NNK.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Nutr.Home page
M. J. Wargovich
Diallylsulfide and Allylmethylsulfide Are Uniquely Effective among Organosulfur Compounds in Inhibiting CYP2E1 Protein in Animal Models
J. Nutr., March 1, 2006; 136(3): 832S - 834S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. El-Bayoumy, R. Sinha, J. T. Pinto, and R. S. Rivlin
Cancer Chemoprevention by Garlic and Garlic-Containing Sulfur and Selenium Compounds
J. Nutr., March 1, 2006; 136(3): 864S - 869S.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Z. Bao, X.-Y. He, X. Ding, S. Prabhu, and J.-Y. Hong
METABOLISM OF NICOTINE AND COTININE BY HUMAN CYTOCHROME P450 2A13
Drug Metab. Dispos., February 1, 2005; 33(2): 258 - 261.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
X.-Y. He, J. Shen, X. Ding, A. Y. H. Lu, and J.-Y. Hong
IDENTIFICATION OF CRITICAL AMINO ACID RESIDUES OF HUMAN CYP2A13 FOR THE METABOLIC ACTIVATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE, A TOBACCO-SPECIFIC CARCINOGEN
Drug Metab. Dispos., December 1, 2004; 32(12): 1516 - 1521.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Guyonnet, C. Belloir, M. Suschetet, M.-H. Siess, and A.-M. Le Bon
Mechanisms of protection against aflatoxin B1 genotoxicity in rats treated by organosulfur compounds from garlic
Carcinogenesis, August 1, 2002; 23(8): 1335 - 1341.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
T. R. Van Vleet, D. W. Bombick, and R. A. Coulombe Jr.
Inhibition of Human Cytochrome P450 2E1 by Nicotine, Cotinine, and Aqueous Cigarette Tar Extract in Vitro
Toxicol. Sci., December 1, 2001; 64(2): 185 - 191.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. A. Milner
A Historical Perspective on Garlic and Cancer
J. Nutr., March 1, 2001; 131(3): 1027S - 1031.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
C. S. Yang, S. K. Chhabra, J.-Y. Hong, and T. J. Smith
Mechanisms of Inhibition of Chemical Toxicity and Carcinogenesis by Diallyl Sulfide (DAS) and Related Compounds from Garlic
J. Nutr., March 1, 2001; 131(3): 1041S - 1045.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
K. Song and J. A. Milner
The Influence of Heating on the Anticancer Properties of Garlic
J. Nutr., March 1, 2001; 131(3): 1054S - 1057.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
L. M. Knowles and J. A. Milner
Possible Mechanism by Which Allyl Sulfides Suppress Neoplastic Cell Proliferation
J. Nutr., March 1, 2001; 131(3): 1061S - 1066.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
H. E. Kleiner, S. V. Vulimiri, L. Miller, W. H. Johnson Jr, C. P. Whitman, and J. DiGiovanni
Oral administration of naturally occurring coumarins leads to altered phase I and II enzyme activities and reduced DNA adduct formation by polycyclic aromatic hydrocarbons in various tissues of SENCAR mice
Carcinogenesis, January 1, 2001; 22(1): 73 - 82.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
M A Gyamfi, N Hokama, K Oppong-Boachie, and Y Aniya
Inhibitory effects of the medicinal herb, Thonningia san gunea, on liver drug metabolizing enzymes of rats
Human and Experimental Toxicology, November 1, 2000; 19(11): 623 - 631.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. D. Premdas, R. J. Bowers, and P.-G. Forkert
Inactivation of Hepatic CYP2E1 by an Epoxide of Diallyl Sulfone
J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 1112 - 1120.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
L. M. Knowles and J. A. Milner
Diallyl disulfide inhibits p34cdc2 kinase activity through changes in complex formation and phosphorylation
Carcinogenesis, June 1, 2000; 21(6): 1129 - 1134.
[Abstract] [Full Text] [PDF]


Home page
Food Science and Technology InternationalHome page
A. Martinez, Y. Ikken, M.I. Cambero, M.L. Marin, A.I. Haza, C. Casas, and P. Morales
Mutagenicity and cytotoxicity of fruits and vegetables evaluated by the Ames test and 3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium bromide (MTT) assay / Mutagenicidad y citotoxicidad de frutas y vegetales evaluadas por el test de Ames y el ensayo del bromuro de 3-(4,5-dimetiltiazol-2-il)-2,5-difeniltetrazolio (MTT)
Food Science and Technology International, January 1, 1999; 5(5): 431 - 437.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.